admin, Author at PsyNews.com

Home Authors Posts by admin

2176 POSTS 0 COMMENTS

https://psynews.com

Pα+ Psychedelic Bulletin #166: Crenshaw and Musk Weigh In on MDMA;...

Raising the Bar: Why Psychedelic Mentorship is Essential For Professional Development

Microdosing as a Coaching Tool: Navigating the Path to Inner Truth

Funding the Future of Psychedelic Medicine in Europe: An Interview with...

Vital 4: Informational Session and Q+A

Transforming Trauma: Community, Connection, and the Healing Power of Vulnerability

Women and Psychedelics: History’s Untold Stories

Pα+ Psychedelic Bulletin #165: A Closer Look at a Buzzy Oral...

Understanding Microdosing: Integrating Small Doses for Big Therapeutic Gains

In Brief: ICER Issues Final Evidence Report and Recommendations Re: MDMA-Assisted...

1...161718...218 Page 17 of 218

EDITOR PICKS

From Huxley to Heffter: Mark Geyer Reflects on a Life in...

Advanced Shadow Work and Psychedelic Integration: A Jungian Path to Wholeness

Essentials of Psychedelic Therapy & Integration

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

ABOUT US

PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.

admin